This inventor holds 10 USPTO granted patents. Top assignee: Kureha Kagaku Kogyo Kabushiki Kaisha. Active years: 1976-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Iwaki, JA (1976)
- Iwaki, JP (1978)
- Tokyo, JP (1983 - 1992)
Company Filing History:
Years Active: 1976-1992
Title: Hidetoshi Kobayashi: Innovator in Pharmaceutical Chemistry
Introduction
Hidetoshi Kobayashi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work focuses on innovative compounds that have potential applications in treating various diseases.
Latest Patents
Among his latest patents is a derivative of dihydroxybenzamide, which is represented by a specific chemical formula. This compound includes variations where R¹ can be a hydrogen atom or a lower alkyl group, while R² can represent various alkyl and cyclo-alkyl groups. Another notable patent is for dialkanoyloxybenzylidene dialkanoate, which is designed for the treatment of inflammatory diseases. This compound also has a defined chemical structure that highlights its potential as an active ingredient in pharmaceutical compositions.
Career Highlights
Hidetoshi Kobayashi is currently associated with Kureha Kagaku Kogyo Kabushiki Kaisha, a company known for its advancements in chemical manufacturing and pharmaceuticals. His work at this organization has allowed him to explore and develop innovative solutions in the pharmaceutical sector.
Collaborations
Throughout his career, Hidetoshi has collaborated with notable colleagues such as Hitoshi Takita and Yutaka Mukaida. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Hidetoshi Kobayashi stands out as a key figure in pharmaceutical innovation, with a focus on developing compounds that address critical health issues. His contributions through patents and collaborations continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
